DAYRA VALENTINO: Open Payments
NPI 1063292365 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 21 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $476 · 2025 $752
Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $234 |
| ABBVIE INC. | 6 | $171 |
| Amneal Pharmaceuticals LLC | 6 | $146 |
| ACADIA Pharmaceuticals Inc | 2 | $107 |
| MDD US Operations, LLC | 3 | $58 |
| UCB, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: INGREZZA, VYALEV, CREXONT, Briviact, AUSTEDO XR, NUPLAZID.
Industry payments across AZ — which companies pay providers there.
